Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum

Clinical Pharmacology and Therapeutics
Z HusseinC J Canfield

Abstract

The population pharmacokinetics of atovaquone were examined in 458 black, Oriental, and Malay patients with acute Plasmodium falciparum malaria receiving atovaquone alone or concomitantly with other drugs. Oral clearance (CL/F) showed a 0.674 power relationship with weight and is similar in Oriental and Malay subjects but 58.5% lower in black subjects. On the basis of mean body weight, the population estimate of CL/F is 3.28, 8.49, and 9.13 L/hr in black, Oriental, and Malay subjects, respectively. The relationship between apparent volume of distribution (V area/F) and weight was linear and similar in all three races at 7.98 L/kg. The population estimate of V area/F is 345, 383, and 428 L in black, Oriental, and Malay subjects, respectively. The bioavailability of the high and low doses of atovaquone was similar. Neither CL/F nor V area/F were significantly affected by age, gender, and the coadministration with chloroguanide (proguanil), pyrimethamine, and tetracycline. Half-life (t1/2) showed a 0.326 power relationship with weight; thus, the population estimate of t1/2 in black, Oriental, and Malay subjects is 72.9, 31.3, and 32.5 hours, respectively. The final magnitudes of interpatient variability in CL/F and V area/F were 6...Continue Reading

References

Jul 1, 1990·Clinical Pharmacology and Therapeutics·H H ZhouG R Wilkinson
Apr 14, 1983·The New England Journal of Medicine·D J Wyler
May 1, 1995·Experimental Parasitology·C J CanfieldW E Gutteridge
Feb 15, 1995·Annals of Internal Medicine·M Stoeckle, A Tennenberg
Nov 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·T J BlanchardP L Chiodini
Jun 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·B S PetersJ Main
Feb 11, 1994·Journal of Chromatography·D V DeAngelisJ L Woolley
Jul 1, 1994·The American Journal of the Medical Sciences·L J EpsteinR D Meyer
Aug 1, 1994·Experimental Parasitology·I IttaratS R Meshnick
Jan 1, 1994·British Journal of Clinical Pharmacology·P E RolanJ Posner
Dec 1, 1993·The Annals of Pharmacotherapy·L G Haile, J F Flaherty

❮ Previous
Next ❯

Citations

Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean-François FaucherPeter G Kremsner
Nov 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gregory A DeyeAlan J Magill
Jan 8, 2013·The Journal of Antimicrobial Chemotherapy·Gemma L NixonGiancarlo A Biagini
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Aaron L Baggish, David R Hill
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·M D EdsteinM F Good
Feb 9, 2008·Emerging Infectious Diseases·Rémy DurandJacques Le Bras
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·F EzzetN J White
Aug 19, 2003·The Annals of Pharmacotherapy·Fawziah MarraMary H H Ensom
Oct 3, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·J A SimpsonN J White
Feb 26, 2008·Archiv der Pharmazie·Martin Schlitzer
Jul 4, 2001·Clinical Pharmacokinetics·P T Giao, P J de Vries
Nov 26, 2005·Expert Review of Anti-infective Therapy·Samir N Patel, Kevin C Kain
Mar 9, 2012·Clinical Pharmacology and Therapeutics·M CellaO Della Pasqua
Nov 9, 2015·European Journal of Drug Metabolism and Pharmacokinetics·Iftekhar MahmoodRita Humeniuk
Nov 21, 2009·The Lancet Infectious Diseases·Reinhold KerbMatthias Schwab

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.